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The  inappropriate  use  of antibiotics  in  upper
respiratory tract  infections:  it  is  time  for  action
Uso  inadequado  de  antibióticos  em  infecc¸ões do  trato  respiratório  superior:t
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Antibiotics  are  one  of  the  greatest  discoveries  in  medicine
and  have  signiﬁcantly  decreased  mortality  and  morbidity
rates  for  infectious  diseases  during  the  last  75  years.  How-
ever,  large  quantities  of  antibiotics  are  utilized  empirically
and  inappropriately,  particularly  for  upper  respiratory  tract
infections.
The  vast  majority  of  these  community-acquired  infec-
tions  is  initially  caused  by  viruses,  self-limited  in  their
clinical  evolution,  and  have  no  need  of  antibiotic  treat-
ment.  A  small  percentage  is  complicated  by  secondary
bacterial  infection  for  which  antibiotics  could  be  useful.
Several  diverse  factors  can  be  responsible  for  this  inap-
propriate  use  of  antibiotics.  There  is  a  lack  of  fast  and
accurate  laboratory  tests  do  differentiate  bacterial  from
viral  infections;  patients  sometimes  believe  that  antibi-
otics  can  relieve  symptoms  such  as  fever  and  pain  and
pressure  doctors  to  prescribe  antibiotics  when  their  symp-
toms  do  not  improve  quickly  with  other  medical  treatment;
doctors  practice  defensive  medicine,  antibiotics  are  avail-
able  without  prescriptions  in  many  countries,  and  doctors
have  difﬁculty  identifying  patients  at  high  risk  of  bacterial
complications,  such  as  the  elderly,  immunocompromised  and
carriers  of  chronic  diseases.
Brazil  is  the  fourth  largest  global  consumer  of  medicines
and  40%  of  these  are  antibiotics.  Since  2011  Brazilian  phar-
macies  are  not  allowed  to  sell  antibiotics  without  a  medical
prescription  and  since  2013  all  pharmacies  have  to  submit
an  electronic  communication  about  antibiotics  prescriptions
to  the  ANVISA  (National  Agency  for  Sanitary  Vigilance).  In
the  ﬁrst  year  after  the  implementation  of  this  policy  there
was  a  20%  decrease  in  antibiotics  prescriptions,  but  soon
thereafter,  the  number  increased  again. Please cite this article as: Pignatari ACC, Myake MM. The inap-
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access article under the CC BY license (https://creativecommons.org/licAllergy,  collateral  effects  such  as  gastrointestinal  symp-
oms  and  toxicity  (hepatic,  renal,  neurologic,  cardiac  and
eratogenicity)  are  well  described,  and  can  occur  with
rug  usage  from  the  majority  of  the  antibiotics  classes.
esistance  to  antibiotics,  sometimes  with  multiresistant
acteria,  is  usually  seen  in  nosocomial  infections  but  also
ccurs  in  community  infections.
Currently  there  are  few  new  available  classes  of  antibi-
tics,  and  it  is  very  important  to  preserve  the  commonly
sed  antibiotics  particularly  the  class  of  B-lactams  that  is
haracterized  by  low  toxicity  in  the  majority  of  patients
ncluding  neonates,  children,  pregnant  woman  and  the
lderly.  When  they  are  indicated  the  basic  criteria  for  antibi-
tic  usage  should  be  reinforced  constantly  in  the  treatment
ased  on  international  and  local  guidelines  for  each  cate-
ory  of  infection.  Collateral  effects  and  toxicity  are  relevant
or  the  patient  as  an  individual  but  bacterial  resistance  is
elevant  for  the  entire  community.
Another  important  recent  topic  is  the  long-term  effects
f  antibiotics  on  the  human  microbiome  that  may  persist
hroughout  an  entire  life  span  and  is  probably  associated
ith  chronic  inﬂammatory  diseases  and  even  to  some  types
f  neoplasia.
All  these  issues  are  important  and  are  addressed
lobally  by  different  institutions  and  scientiﬁc  societies,
overnments,  ONGs  and  private  organizations  promoting
he  rational  use  of  antibiotics.  Doctors,  pharmacists  and
atients  are  co-responsible  for  the  success  of  this  endeavor
nd  otorhinolaryngologists  must  be  fully  involved.  More
fforts  in  education,  training  and  research  are  warranted,
ut  the  effort  of  each  individual  is  essential  at  this
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